Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

Summer is creeping closer, and for Gilead Sciences that only means one thing: the much-anticipated launch of long-acting HIV ...

Data from the last five years show that many people who contracted HIV had seen a provider in the year before.

Dallas is at the center of an urgent public health crisis. The city has the highest rate of new HIV infections in Texas, ...

Despite steep budget and staffing cuts at the FDA in recent weeks and other headwinds, Gilead CEO Daniel O’Day assured investors that the pharma’s plans and preparations for lenacapavir’s launch ...

But on Monday, the US Supreme Court heard oral arguments in a case that could gut the part of the Affordable Care Act that ...

A company wanted to stop covering PrEP because it "facilitates homosexual behavior." They could upend preventative care for ...

SPRINGFIELD The Illinois Department of Public Health (IDPH) has issued a standing order that will allow Illinoisans to obtain ...

A new study published in the journal of JAC-Antimicrobial Resistance showed that the pre-exposure preventive doxycycline ...